Serum Chromium Levels and its Relation with PCOS: A Review Search
Keywords:
PCOS, Chromium supplementation, Diabetes
Abstract
Objective: PCOS: Polycystic ovarian syndrome is a general form between procreation age women which be able to effect in increases death rate also ailments in women owing to increasing the diabetes plus fats risk also the diseases of cardiovascular. This study planed to review the efficiency of usually PCOS curing on the diabetes predicted in PCOS women without diabetic.
Materials & methods: A broad investigate was achieved on the scientific journals from 1986 till 2023. A whole of 62 articles involving examination, also analysis are including in this review article.
Results: In PCOS women, this review discovered the change of daily life may be case limited effects included heaviness and obese decreasing might not obtained via medicinal innovations. Chromium supplement can illustrate in expansion in PCOS women.
Conclusion: Grouping of daily life adjustment through chromium supplement may improve the effect of the PCOS avoidance, as well as discover a special response to management in non- fat comparing with fat PCOS women.
References
1. Ricardo Azziz 1, Keslie S Woods, Rosario Reyna, Timothy J Key, Eric S Knochenhauer , Bulent O Yildiz: The prevalence and features of the polycysticovary syndrome in an unselected population. J Clin Endocrinol Metab. 89 (6): 2745-2749, 2004.
2. Ricardo Azziz , Enrico Carmina, Didier Dewailly, Evanthia Diamanti-Kandarakis, Héctor F Escobar-Morreale, Walter Futterweit, Onno E Janssen, Richard S Legro, Robert J Norman, Ann E Taylor, Selma F Witchel,The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report, Fertil Steril 91(2): 456-488. 2009
3. M Hickey 1, D A Doherty, H Atkinson, D M Sloboda, S Franks, R J Norman, R Hart, Clinical, ultrasound and biochemicalfeatures of polycystic ovary syndrome in adolescents: implications fordiagnosis. Hum Reprod 26(6): 1469-1477, 2011.
4. Seddigheh Esmaeilzadeh, Mouloud Agajani Delavar, Mania Amiri, Soraya Khafri, Nargess Gholizadeh Pasha, Polycystic ovary syndrome in Iranian adolescents, Int J Adolesc Med Health 26 (4): 559–565, 2014.
5. Lea S Vilmann 1, Ebbe Thisted, Jennifer L Baker, Jens-Christian Holm, Development of obesity and polycystic ovary syndrome in adolescents, Horm Res Paediatr 78(5-6): 269-278. 2012.
6. Brooke Rossi 1, Sara Sukalich, Jennifer Droz, Adam Griffin, Stephen Cook, Aaron Blumkin, David S Guzick, Kathleen M Hoeger, Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome, J Clin Endocrinol Metab . 93 (12): 4780-4786, 2008.
7. Holley F Allen 1, Cristina Mazzoni, Rubina A Heptulla, Mary A Murray, Nancy Miller, Laura Koenigs, Edward O Reiter, Randomized controlled trial evaluating response to metformin versus standard therapy in the treatment of adolescents with polycystic ovary syndrome, J Pediatr Endocrinol Metab 18 (8): 761-768, 2008.
8. Teresa Sir-Petermann 1, Ethel Codner, Virginia Pérez, Bárbara Echiburú, Manuel Maliqueo, Amanda Ladrón de Guevara, Jessica Preisler, Nicolás Crisosto, Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome, J Clin Endocrinol Metab 94 (6): 1923-1930, 2009.
9. Mariana K Toscani 1, Fernanda M Mario, Simone Radavelli-Bagatini, Poli Mara Spritzer, Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome, Nutr Res 31(2): 97-103, 2011.
10. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome, Fertil Steril. 81(1): 19-25. 2004.
11. Piotrowska A, PilchW, Tota Ł, Nowak G, Biological significance of chromium III for the human organism, Med Pr 69(2): 211–223, 2018.
12. Brown RO, Forloines-Lynn S, Cross RE, Heizer WD., Chromium deficiency after long-term total parenteral nutrition. Dig Dis Sci. 31(6): 661-664, 1986.
13. Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A., Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr. 30(4): 531-538, 1977.
14. Anna Piotrowska; Wanda Pilch, Olga Czerwińska-Ledwig; Roxana Zuziak; Agata Siwek; Małgorzata Wolak; Gabriel Nowak, The Possibilities of Using Chromium Salts as an Agent Supporting Treatment of Polycystic Ovary Syndrome, Biological Trace Element Research 192: 91-97, 2019.
15. Chen T, Chen Y, Liu C et al, Effect of chromium supplementationon element distribution in a mouse model of polycystic ovary syndrome. Biol Trace Elem Res 168(2): 472-480, 2015.
16. Chen T, Chen Y, Liu C et al, Steroidogenic enzymes of adipose tissue in modulation of trivalent chromium in a mousemodel of PCOS. Gynecol Endocrinol 33(1): 48-52, 2017.
17. Spritzer PM, Lecke SB, Fabris VC, Ziegelmann PK, Amaral L, Blood trace element concentrations in polycystic ovary syndrome:systematic review and meta-analysis. Biol Trace Elem Res 175(2): 254-262, 2016.
18. Amr N, Abdel-Rahim HE , The effect of chromium supplementation on polycystic ovary syndrome in adolescents. J PediatrAdolesc Gynecol 28(2): 114-118, 2015.
19. Fazelian S, Rouhani MH, Bank SS, Amani R , Chromium supplementation and polycystic ovary syndrome: a systematic review and meta-analysis. J Trace Elem Med Biol 42: 92-96, 2017.
20. Heshmati J, Omani-Samani R, Vesali S, Maroufizadeh S,Rezaeinejad M, Razavi M, Sepidarkish M, The effects of supplementation with chromium on insulin resistance indices in women with polycystic ovarian syndrome: a systematic review and meta-analysis of randomized clinical trials. Horm Metab Res 50(3): 193-200, 2018.
21. Maleki V, Izadi A, Farsad-Naeimi A, Alizadeh M, Chromium supplementation does not improve weight loss or metabolic and hormonal variables in patients with polycystic ovary syndrome: a systematic review. Nutr Res 56: 1-10, 2018.
22. Tang XL, Sun Z, Gong L, Chromium supplementation in women with polycystic ovary syndrome: systematic review and meta-analysis. J Obstet Gynaecol Res 44(1): 134-143, 2018.
23. Ashoush S, Abou Gamrah A, Bayoumy H, Othman N , Chromium picolinate reduces insulin resistance in polycystic ovary syndrome: randomized controlled trial. J Obstet Gynaecol Res 42: 279-285, 2016.
24. Jamilian M, Asemi Z, Chromium supplementation and the effects on metabolic status in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial, Ann Nutr Metab 67: 42-48, 2015.
25. Lucidi RS, Thyer AC, Easton CA, Holden AEC, Schenken RS, Brzyski RG, Effect of chromium supplementation on insulin resistance and ovarian and menstrual cyclicity in women with polycystic ovary syndrome, Fertil Steril 84: 1755-1777, 2005.
26. Amooee S, Parsanezhad ME, Shirazi MR et al., Metformin versus chromium picolinate in clomiphene citrate-resistant patients with PCOs: a double-blind randomized clinical trial. Iran J Reprod Med 11: 611-618, 2013.
27. Fogle RH, BakerMB, Patel SK, Korst LM, Stanczyk FZ, Sokol RZ , A prospective, randomized clinical trial comparing chromium picolinate to metformin for the treatment of insulin resistance in obese, Hispanic women with polycystic ovarian syndrome. Fertil Steril 88: S181, 2007.
28. R Riales, M J Albrink, Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men, Am J Clin Nutr 34 (12): 2670-2678, 1981.
29. Sherif Ashoush, Amgad Abou-Gamrah, Hassan Bayoumy and Noura Othman , Chromium picolinate reduces insulin resistance in polycystic ovary syndrome: Randomized controlled trial, J. Obstet. Gynaecol. Res. 42, No. 3: 279-285, 2016.
30. Kurek G, Babiarczyk B. , Biopsychosocial problems experienced by women at reproductive age suffering from polycystic ovary syndrome., Pol Prz Nauk Zdr. 1(50): 7-15, 2017.
31. Cooney LG, Lee I, Sammel MD, Dokras A, High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis, Hum Reprod 32(5): 1075-1091, 2017.
32. Attenburrow MJ, Odontiadis J, Murray BJ, Chromium treatment decreases the sensitivity of 5HT2A receptors. Psychopharmacology 159: 432-436, 2002.
33. Piotrowska A,Młyniec K, Siwek A, DybałaM, OpokaW, Poleszak E, Nowak G, Antidepressant-like effect of chromium chloride in the mouse forced swim test: involvement of glutamatergic and serotonergic receptors. Pharmacol Rep 60(6): 991-995, 2008.
34. Piotrowska A, Siwek A,Wolak M, Pochwat B, Szewczyk B, Opoka W, Poleszak E, Nowak G, Involvement of the monoaminergic system in the antidepressant-like activity of chromium chloride in the forced swim test. J Physiol Pharmacol 64(4): 493-498, 2013.
35. Czerwińska D, Zadrużna M, Estimation of chrome and its main sources in the diets of people at advanced age suffering from diabetes. Żyw Człow Metab 30: 816-821, 2003.
36. Skibniewska K,Wyszkowska M, KotW et al., The content of chromium in the food rations of UWM students in Olsztyn. Żyw Człow Metab 34: 788-791, 2007. (Polish)
37. Davidson JR, Abraham K, Connor KM, McLeod MN, Effectiveness of chromium in atypical depression: a placebocontrolled trial. Biol Psychiatry 53: 261-264, 2003.
38. Docherty JP, Sack DA, Hoffman M et al., A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate craving. J Psychiat Pract 11: 302-314, 2005.
39. McLeod MN, Golden RN, Chromium treatment of depression. Int J Neuropsychopharmacol 3: 311-314, 2000.
40. Z Kurdoglu 1, M Kurdoglu, H Demir, H G Sahin,Serum trace elements and heavy metals in polycystic ovary syndrome, Hum Exp Toxicol. 31(5): 452-456, 2012.
41. Guanchao Zheng 1, Lijun Wang, Zhizhun Guo, Lingbin Sun, Lingling Wang, Chonggang Wang, Zhenghong Zuo, Huiling Qiu, Association of Serum Heavy Metals and Trace Element Concentrations with Reproductive Hormone Levels and Polycystic Ovary Syndrome in a Chinese Population, Biol Trace Elem Res. 167(1): 1-10, 2015.
42. N. Amr, H.E. Abdel-Rahim, The Effect of Chromium Supplementation on Polycystic Ovary Syndrome in Adolescents, J Pediatr Adolesc Gynecol 28 :114e118, 2015.
43. Pratip Chakraborty 1, Sanghamitra Ghosh, S K Goswami, Syed N Kabir, Baidyanath Chakravarty, Kuladip Jana, Altered trace mineral milieu might play an aetiological role in the pathogenesis of polycystic ovary syndrome, Biol Trace Elem Res,152 (1): 9-15, 2013.
44. Mehri Jamilian & Ollah Asemib, Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial, Annals of Nutrition & Metabolism 67: 42–48, 2015.
45. N Suksomboon 1, N Poolsup, A Yuwanakorn, Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes, J Clin Pharm Ther. 39 (3): 292-306, 2014.
46. Davis W. Lamson & Steven M. Plaza, The safety and efficacy of high-dose chromium, Alternative Medicine Review 7(3): 218-235, 2002.
47. R A Anderson , N Cheng, N A Bryden, M M Polansky, N Cheng, J Chi, J Feng, Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes, Diabetes 46(11): 1786-1791, 1997.
48. R Scott Lucidi 1, Angela C Thyer, Carol A Easton, Alan E C Holden, Robert S Schenken, Robert G Brzyski, Effect of chromium supplementation on insulin resistance and ovarian and menstrual cyclicity in women with polycystic ovary syndrome, Fertil Steril 84(6): 1755-1757, 2005.
49. Michael L Lydic 1, Margaret McNurlan, Shirley Bembo, Lina Mitchell, Eugene Komaroff , Marie Gelato, Chromium picolinate improves insulin sensitivity in obese subjects with polycystic ovary syndrome, Fertil Steril 86(1): 243-246. 2006.
50. Sedigheh Amooee, Mohammad Ebrahim Parsanezhad, Maryam Ravanbod Shirazi, Saeed Alborzi, Alamtaj Samsami, Metformin versus chromium picolinate in clomiphene citrate-resistant patients with PCOs: A double-blind randomized clinical trial, Iran J Reprod Med . 11(8): 611-618, 2013.
51. Seth A Stein1, Margaret Mc Nurlan, Brett T Phillips2, Catherine Messina3, Dennis Mynarcik1 and Marie Gelato1, Chromium Therapy for Insulin Resistance Associated with HIV-Disease, J AIDS Clin Res 4(9): 239, 2013.
52. Javad Heshmati, Reza Omani-Samani, Samira Vesali, Saman Maroufizadeh, Mahroo Rezaeinejad, Maryam Razavi, Mahdi Sepidarkish, The Effects of Supplementation with Chromium on Insulin Resistance Indices in Women with Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials, Horm Metab Res 50 (03): 193-200, 2018.
53. Asbaghi O., Fatemeh N., Mahnaz R.K., Ehsan G., Elham E., Behzad N., Damoon A.L., Amirmansour A.N. Effects of chromium supplementation on glycemic control in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 161:105098, 2020.
54. Dubey P., Thakur V., Chattopadhyay M. Role of Minerals and Trace Elements in Diabetes and Insulin Resistance. Nutrients. 12:1864, 2020.
55. Maleki V., Izadi A., Farsad-Naeimi A., Alizadeh M. Chromium supplementation does not improve weight loss or metabolic and hormonal variables in patients with polycystic ovary syndrome: A systematic review. Nutr. Res. 56: 1–10, 2018.
56. Tamer F. Borg, Asmaa G. Sayed Hasan, Mohamed S. Khallaf, Hossam M.M. Hemeda, Marwan O. Elkady, Role of Chromium Versus Metformin Supplementations as Adjuvant for Ovulation Induction By Clomiphene Citrate in Infertile Patients With Polycystic Ovary Syndrome: Randomized Controlled Trial, Evidence Based Women's Health Journal 12(2): 166-176, 2022.
57. Tahra ElObeid, Marwa Osman Awad, Vijay Ganji, Joyce Moawad, The Impact of Mineral Supplementation on Polycystic Ovarian Syndrome, Metabolites. 12(4): 338, 2022.
58. Priya Sharma 1, Vartika Gupta 2, Kush Kumar 2, Preeti Khetarpal, Assessment of Serum Elements Concentration and Polycystic Ovary Syndrome (PCOS): Systematic Review and Meta-analysis, Biol Trace Elem Res 200(11): 4582-4593, 2022.
59. Capone K., Sentongo T. The ABCs of Nutrient Deficiencies and Toxicities. Pediatr. Ann. 48: e434–e440, 2019.
60. Balali-Mood M., Naseri K., Tahergorabi Z., Khazdair M.R., Sadeghi M. Toxic Mechanisms of Five Heavy Metals: Mercury, Lead, Chromium, Cadmium, and Arsenic. Front. Pharmacol. 12:643972, 2021.
61. Gröber, U.; Schmidt, J.; Kisters, K. Magnesium in Prevention and Therapy. Nutrients 7: 8199–8226, 2015.
62. Ayat Kareem Ali, Salam A.H. Al-Ameri, Amer H. Abdullah, Maani A. Azam, Pearson Correlation and ROC curve analysis of trace elements Zn, Cu, Cr, Mg and Ca Level in PCOS patients, History of medicine 9(1), 1769-1774, 2023.
2. Ricardo Azziz , Enrico Carmina, Didier Dewailly, Evanthia Diamanti-Kandarakis, Héctor F Escobar-Morreale, Walter Futterweit, Onno E Janssen, Richard S Legro, Robert J Norman, Ann E Taylor, Selma F Witchel,The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report, Fertil Steril 91(2): 456-488. 2009
3. M Hickey 1, D A Doherty, H Atkinson, D M Sloboda, S Franks, R J Norman, R Hart, Clinical, ultrasound and biochemicalfeatures of polycystic ovary syndrome in adolescents: implications fordiagnosis. Hum Reprod 26(6): 1469-1477, 2011.
4. Seddigheh Esmaeilzadeh, Mouloud Agajani Delavar, Mania Amiri, Soraya Khafri, Nargess Gholizadeh Pasha, Polycystic ovary syndrome in Iranian adolescents, Int J Adolesc Med Health 26 (4): 559–565, 2014.
5. Lea S Vilmann 1, Ebbe Thisted, Jennifer L Baker, Jens-Christian Holm, Development of obesity and polycystic ovary syndrome in adolescents, Horm Res Paediatr 78(5-6): 269-278. 2012.
6. Brooke Rossi 1, Sara Sukalich, Jennifer Droz, Adam Griffin, Stephen Cook, Aaron Blumkin, David S Guzick, Kathleen M Hoeger, Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome, J Clin Endocrinol Metab . 93 (12): 4780-4786, 2008.
7. Holley F Allen 1, Cristina Mazzoni, Rubina A Heptulla, Mary A Murray, Nancy Miller, Laura Koenigs, Edward O Reiter, Randomized controlled trial evaluating response to metformin versus standard therapy in the treatment of adolescents with polycystic ovary syndrome, J Pediatr Endocrinol Metab 18 (8): 761-768, 2008.
8. Teresa Sir-Petermann 1, Ethel Codner, Virginia Pérez, Bárbara Echiburú, Manuel Maliqueo, Amanda Ladrón de Guevara, Jessica Preisler, Nicolás Crisosto, Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome, J Clin Endocrinol Metab 94 (6): 1923-1930, 2009.
9. Mariana K Toscani 1, Fernanda M Mario, Simone Radavelli-Bagatini, Poli Mara Spritzer, Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome, Nutr Res 31(2): 97-103, 2011.
10. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome, Fertil Steril. 81(1): 19-25. 2004.
11. Piotrowska A, PilchW, Tota Ł, Nowak G, Biological significance of chromium III for the human organism, Med Pr 69(2): 211–223, 2018.
12. Brown RO, Forloines-Lynn S, Cross RE, Heizer WD., Chromium deficiency after long-term total parenteral nutrition. Dig Dis Sci. 31(6): 661-664, 1986.
13. Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A., Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr. 30(4): 531-538, 1977.
14. Anna Piotrowska; Wanda Pilch, Olga Czerwińska-Ledwig; Roxana Zuziak; Agata Siwek; Małgorzata Wolak; Gabriel Nowak, The Possibilities of Using Chromium Salts as an Agent Supporting Treatment of Polycystic Ovary Syndrome, Biological Trace Element Research 192: 91-97, 2019.
15. Chen T, Chen Y, Liu C et al, Effect of chromium supplementationon element distribution in a mouse model of polycystic ovary syndrome. Biol Trace Elem Res 168(2): 472-480, 2015.
16. Chen T, Chen Y, Liu C et al, Steroidogenic enzymes of adipose tissue in modulation of trivalent chromium in a mousemodel of PCOS. Gynecol Endocrinol 33(1): 48-52, 2017.
17. Spritzer PM, Lecke SB, Fabris VC, Ziegelmann PK, Amaral L, Blood trace element concentrations in polycystic ovary syndrome:systematic review and meta-analysis. Biol Trace Elem Res 175(2): 254-262, 2016.
18. Amr N, Abdel-Rahim HE , The effect of chromium supplementation on polycystic ovary syndrome in adolescents. J PediatrAdolesc Gynecol 28(2): 114-118, 2015.
19. Fazelian S, Rouhani MH, Bank SS, Amani R , Chromium supplementation and polycystic ovary syndrome: a systematic review and meta-analysis. J Trace Elem Med Biol 42: 92-96, 2017.
20. Heshmati J, Omani-Samani R, Vesali S, Maroufizadeh S,Rezaeinejad M, Razavi M, Sepidarkish M, The effects of supplementation with chromium on insulin resistance indices in women with polycystic ovarian syndrome: a systematic review and meta-analysis of randomized clinical trials. Horm Metab Res 50(3): 193-200, 2018.
21. Maleki V, Izadi A, Farsad-Naeimi A, Alizadeh M, Chromium supplementation does not improve weight loss or metabolic and hormonal variables in patients with polycystic ovary syndrome: a systematic review. Nutr Res 56: 1-10, 2018.
22. Tang XL, Sun Z, Gong L, Chromium supplementation in women with polycystic ovary syndrome: systematic review and meta-analysis. J Obstet Gynaecol Res 44(1): 134-143, 2018.
23. Ashoush S, Abou Gamrah A, Bayoumy H, Othman N , Chromium picolinate reduces insulin resistance in polycystic ovary syndrome: randomized controlled trial. J Obstet Gynaecol Res 42: 279-285, 2016.
24. Jamilian M, Asemi Z, Chromium supplementation and the effects on metabolic status in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial, Ann Nutr Metab 67: 42-48, 2015.
25. Lucidi RS, Thyer AC, Easton CA, Holden AEC, Schenken RS, Brzyski RG, Effect of chromium supplementation on insulin resistance and ovarian and menstrual cyclicity in women with polycystic ovary syndrome, Fertil Steril 84: 1755-1777, 2005.
26. Amooee S, Parsanezhad ME, Shirazi MR et al., Metformin versus chromium picolinate in clomiphene citrate-resistant patients with PCOs: a double-blind randomized clinical trial. Iran J Reprod Med 11: 611-618, 2013.
27. Fogle RH, BakerMB, Patel SK, Korst LM, Stanczyk FZ, Sokol RZ , A prospective, randomized clinical trial comparing chromium picolinate to metformin for the treatment of insulin resistance in obese, Hispanic women with polycystic ovarian syndrome. Fertil Steril 88: S181, 2007.
28. R Riales, M J Albrink, Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men, Am J Clin Nutr 34 (12): 2670-2678, 1981.
29. Sherif Ashoush, Amgad Abou-Gamrah, Hassan Bayoumy and Noura Othman , Chromium picolinate reduces insulin resistance in polycystic ovary syndrome: Randomized controlled trial, J. Obstet. Gynaecol. Res. 42, No. 3: 279-285, 2016.
30. Kurek G, Babiarczyk B. , Biopsychosocial problems experienced by women at reproductive age suffering from polycystic ovary syndrome., Pol Prz Nauk Zdr. 1(50): 7-15, 2017.
31. Cooney LG, Lee I, Sammel MD, Dokras A, High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis, Hum Reprod 32(5): 1075-1091, 2017.
32. Attenburrow MJ, Odontiadis J, Murray BJ, Chromium treatment decreases the sensitivity of 5HT2A receptors. Psychopharmacology 159: 432-436, 2002.
33. Piotrowska A,Młyniec K, Siwek A, DybałaM, OpokaW, Poleszak E, Nowak G, Antidepressant-like effect of chromium chloride in the mouse forced swim test: involvement of glutamatergic and serotonergic receptors. Pharmacol Rep 60(6): 991-995, 2008.
34. Piotrowska A, Siwek A,Wolak M, Pochwat B, Szewczyk B, Opoka W, Poleszak E, Nowak G, Involvement of the monoaminergic system in the antidepressant-like activity of chromium chloride in the forced swim test. J Physiol Pharmacol 64(4): 493-498, 2013.
35. Czerwińska D, Zadrużna M, Estimation of chrome and its main sources in the diets of people at advanced age suffering from diabetes. Żyw Człow Metab 30: 816-821, 2003.
36. Skibniewska K,Wyszkowska M, KotW et al., The content of chromium in the food rations of UWM students in Olsztyn. Żyw Człow Metab 34: 788-791, 2007. (Polish)
37. Davidson JR, Abraham K, Connor KM, McLeod MN, Effectiveness of chromium in atypical depression: a placebocontrolled trial. Biol Psychiatry 53: 261-264, 2003.
38. Docherty JP, Sack DA, Hoffman M et al., A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate craving. J Psychiat Pract 11: 302-314, 2005.
39. McLeod MN, Golden RN, Chromium treatment of depression. Int J Neuropsychopharmacol 3: 311-314, 2000.
40. Z Kurdoglu 1, M Kurdoglu, H Demir, H G Sahin,Serum trace elements and heavy metals in polycystic ovary syndrome, Hum Exp Toxicol. 31(5): 452-456, 2012.
41. Guanchao Zheng 1, Lijun Wang, Zhizhun Guo, Lingbin Sun, Lingling Wang, Chonggang Wang, Zhenghong Zuo, Huiling Qiu, Association of Serum Heavy Metals and Trace Element Concentrations with Reproductive Hormone Levels and Polycystic Ovary Syndrome in a Chinese Population, Biol Trace Elem Res. 167(1): 1-10, 2015.
42. N. Amr, H.E. Abdel-Rahim, The Effect of Chromium Supplementation on Polycystic Ovary Syndrome in Adolescents, J Pediatr Adolesc Gynecol 28 :114e118, 2015.
43. Pratip Chakraborty 1, Sanghamitra Ghosh, S K Goswami, Syed N Kabir, Baidyanath Chakravarty, Kuladip Jana, Altered trace mineral milieu might play an aetiological role in the pathogenesis of polycystic ovary syndrome, Biol Trace Elem Res,152 (1): 9-15, 2013.
44. Mehri Jamilian & Ollah Asemib, Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial, Annals of Nutrition & Metabolism 67: 42–48, 2015.
45. N Suksomboon 1, N Poolsup, A Yuwanakorn, Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes, J Clin Pharm Ther. 39 (3): 292-306, 2014.
46. Davis W. Lamson & Steven M. Plaza, The safety and efficacy of high-dose chromium, Alternative Medicine Review 7(3): 218-235, 2002.
47. R A Anderson , N Cheng, N A Bryden, M M Polansky, N Cheng, J Chi, J Feng, Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes, Diabetes 46(11): 1786-1791, 1997.
48. R Scott Lucidi 1, Angela C Thyer, Carol A Easton, Alan E C Holden, Robert S Schenken, Robert G Brzyski, Effect of chromium supplementation on insulin resistance and ovarian and menstrual cyclicity in women with polycystic ovary syndrome, Fertil Steril 84(6): 1755-1757, 2005.
49. Michael L Lydic 1, Margaret McNurlan, Shirley Bembo, Lina Mitchell, Eugene Komaroff , Marie Gelato, Chromium picolinate improves insulin sensitivity in obese subjects with polycystic ovary syndrome, Fertil Steril 86(1): 243-246. 2006.
50. Sedigheh Amooee, Mohammad Ebrahim Parsanezhad, Maryam Ravanbod Shirazi, Saeed Alborzi, Alamtaj Samsami, Metformin versus chromium picolinate in clomiphene citrate-resistant patients with PCOs: A double-blind randomized clinical trial, Iran J Reprod Med . 11(8): 611-618, 2013.
51. Seth A Stein1, Margaret Mc Nurlan, Brett T Phillips2, Catherine Messina3, Dennis Mynarcik1 and Marie Gelato1, Chromium Therapy for Insulin Resistance Associated with HIV-Disease, J AIDS Clin Res 4(9): 239, 2013.
52. Javad Heshmati, Reza Omani-Samani, Samira Vesali, Saman Maroufizadeh, Mahroo Rezaeinejad, Maryam Razavi, Mahdi Sepidarkish, The Effects of Supplementation with Chromium on Insulin Resistance Indices in Women with Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials, Horm Metab Res 50 (03): 193-200, 2018.
53. Asbaghi O., Fatemeh N., Mahnaz R.K., Ehsan G., Elham E., Behzad N., Damoon A.L., Amirmansour A.N. Effects of chromium supplementation on glycemic control in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 161:105098, 2020.
54. Dubey P., Thakur V., Chattopadhyay M. Role of Minerals and Trace Elements in Diabetes and Insulin Resistance. Nutrients. 12:1864, 2020.
55. Maleki V., Izadi A., Farsad-Naeimi A., Alizadeh M. Chromium supplementation does not improve weight loss or metabolic and hormonal variables in patients with polycystic ovary syndrome: A systematic review. Nutr. Res. 56: 1–10, 2018.
56. Tamer F. Borg, Asmaa G. Sayed Hasan, Mohamed S. Khallaf, Hossam M.M. Hemeda, Marwan O. Elkady, Role of Chromium Versus Metformin Supplementations as Adjuvant for Ovulation Induction By Clomiphene Citrate in Infertile Patients With Polycystic Ovary Syndrome: Randomized Controlled Trial, Evidence Based Women's Health Journal 12(2): 166-176, 2022.
57. Tahra ElObeid, Marwa Osman Awad, Vijay Ganji, Joyce Moawad, The Impact of Mineral Supplementation on Polycystic Ovarian Syndrome, Metabolites. 12(4): 338, 2022.
58. Priya Sharma 1, Vartika Gupta 2, Kush Kumar 2, Preeti Khetarpal, Assessment of Serum Elements Concentration and Polycystic Ovary Syndrome (PCOS): Systematic Review and Meta-analysis, Biol Trace Elem Res 200(11): 4582-4593, 2022.
59. Capone K., Sentongo T. The ABCs of Nutrient Deficiencies and Toxicities. Pediatr. Ann. 48: e434–e440, 2019.
60. Balali-Mood M., Naseri K., Tahergorabi Z., Khazdair M.R., Sadeghi M. Toxic Mechanisms of Five Heavy Metals: Mercury, Lead, Chromium, Cadmium, and Arsenic. Front. Pharmacol. 12:643972, 2021.
61. Gröber, U.; Schmidt, J.; Kisters, K. Magnesium in Prevention and Therapy. Nutrients 7: 8199–8226, 2015.
62. Ayat Kareem Ali, Salam A.H. Al-Ameri, Amer H. Abdullah, Maani A. Azam, Pearson Correlation and ROC curve analysis of trace elements Zn, Cu, Cr, Mg and Ca Level in PCOS patients, History of medicine 9(1), 1769-1774, 2023.
Published
2023-12-21
How to Cite
Al-Ameri, S. A. H., Abdullah, A. H., & Ali, A. K. (2023). Serum Chromium Levels and its Relation with PCOS: A Review Search. Central Asian Journal of Medical and Natural Science, 4(6), 1131-1142. Retrieved from https://cajmns.casjournal.org/index.php/CAJMNS/article/view/2201
Section
Articles
